CP-547632
Cat. No.:YN440261
产品名称: | CP-547632 |
CAS No.: | 252003-65-9 |
Chemical Name: | 3-[(4-bromo-2,6-difluorophenyl)methoxy]-5-[[[[4-(1-pyrrolidinyl)butyl]amino]carbonyl]amino]-4-isothiazolecarboxamide |
Synonyms: | CP547632 |
分子量: | 532.40 |
分子式: | C₂₀H₂₄BrF₂N₅O₃S |
SMILES: | O=C(NC1=C(C(N)=O)C(OCC2=C(F)C=C(Br)C=C2F)=NS1)NCCCCN3CCCC3 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | CP-547632 是一种口服有效的,ATP 竞争性的VEGFR-2和FGF激酶抑制剂,IC50分别为 11 nM 和 9 nM。CP-547632 对 VEGFR2 和 bFGF 的选择性高于 EGFR,PDGFRβ 和相关的酪氨酸激酶 (TKs)。CP-547632 具有抗肿瘤作用。 |
IC50和靶点: | [{name:"VEGFR-2:11 nM (IC50)"},{name: "FGFR:9 nM (IC50)"}] |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Beebe, J.S., Jani, J.P., Knauth, E., et al.Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapyCancer Res.63(21),7301-7309(2003)